Le Lézard
Classified in: Science and technology, Business
Subjects: TNM, SHA

LookSmart Group Recommends Shareholders Reject Unsolicited Tender Offer by Alternative Liquidity Capital


LookSmart Group (LKST) Recommends Shareholders Reject Unsolicited Tender Offer   

HENDERSON, Nev., Aug. 23, 2022 /PRNewswire/ -- LookSmart Group (OTCMARKETS SYMBOL: LKST) (https://www.otcmarkets.com/stock/LKST/overview), LookSmart Group Inc. ("LookSmart" or the "Company") is making this announcement in compliance with SEC regulation 14e-2 in order to inform shareholders of the Company's position with respect to the following tender offer. LookSmart is in no way associated with Alternative Liquidity Capital and recommends stockholders reject the unsolicited mini-tender offer by Alternative Liquidity for the purchase of up to 21,000 shares which represent 37% of the shares at $2 per share.

Reasons for Recommending Shareholders Reject the Tender Offer:
  1. Alternative Liquidity Capital's Tender Offer is Below LookSmart's Last Share Price: Alternative Liquidity's offer price of $2.00 per share is Ninety Two and 3/100 (92.3%) Percent below the last traded price of $26.00 per share and is also Twenty-two Percent (22%) below the bid price of $2.55 in the stock price quotation at otcmarkets.com https://www.otcmarkets.com/stock/LKST/overview. Therefore, we recommend rejecting the bidder's tender offer per SEC regulation 14e-2(a)(1).
  2. LookSmart is in no way associated with Alternative Liquidity Capital.

Accordingly, please exercise extreme caution and undertake due diligence when reviewing Alternative Liquidity's offer.

About LookSmart Group Inc.

LookSmart is an online advertising solutions company. LookSmart is based in Henderson, Nevada.  For more information, contact us at: [email protected]  or call ?(702) 625-2269.

FORWARD-LOOKING STATEMENTS

This Statement may contain statements that are forward-looking. Forward-looking statements are subject to known and unknown risks and uncertainties and are based on potentially inaccurate assumptions that could cause actual results to differ materially from those expected or implied by the forward-looking statements. Among the important factors that could cause actual results to differ materially from those in any forward-looking statements are (1) the risk of failing to complete any strategic transaction contemplated by any indications of interest for any reason, including the risk that third parties withdraw such indications of interest, (2) LookSmart's ability to maintain the value of its assets, operations and prospects (3) LookSmart's ability to deliver high quality traffic to advertisers and high value advertising opportunities to publishers (4) LookSmart's ability to capture market opportunities, and achieve growth and value based on its investments and growth opportunities (5) business disruptions associated with the tender offer commenced by Alternative Liquidity and (6) other factors detailed in LookSmart's filings with the OTCMarkets.com

Disclosure: If any material change occurs in the disclosure required by this section, the subject company shall promptly publish or send or give a statement disclosing such material change to security holders.

SOURCE LOOKSMART


These press releases may also interest you

at 06:13
eWTP Arabia Capital Technology Fund I ("Techology Fund I"), managed by eWTP Arabia Capital ("eWTPA"), one of the leading private equity firms in the Middle East, was listed in the Preqin League Tables as the the fifth top-performing VC funds in the...

18 mai 2024
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

18 mai 2024
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

18 mai 2024
"Maximizing customer retention and expansion is more important than ever for B2B SaaS companies," said Steven Forth, CEO of Ibbaka. "Our...

18 mai 2024
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...

18 mai 2024
Mirum Pharmaceuticals, Inc. today announced data presented during the 56th European Society for Paediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting which took place this week in Milan, Italy. Data from LIVMARLI®...



News published on and distributed by: